Brian James Miller
CIK: 0002157846
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)1 (100.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
CLOV
CLOVER HEALTH INVESTMENTS, CORP. /DE
Director
Discretionary Trading P&L
Holdings
About Miller Brian James
Miller Brian James (SEC CIK 0002157846) files insider reports with the SEC as Director of CLOVER HEALTH INVESTMENTS, CORP. /DE (CLOV).
Signal8 holds 2 ownership filings by Miller Brian James (1 Form 3, 1 Form 4), filed between Oct 1, 2026 and Oct 2, 2026. Those filings report 1 transaction, the latest on Sep 30, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Miller Brian James's filings is in WILMINGTON, DE.
Recent filings by Miller Brian James
- Sep 30, 2026: Grant or award of CLOV shares (Form 4, code A).
Other insiders filing for CLOVER HEALTH INVESTMENTS, CORP. /DE (CLOV)
- Soares Karen, Chief Legal Officer
- Reynoso Jamie L., CEO, Medicare Advantage
- Toy Andrew, Chief Executive Officer
- THORNTON JOSEPH CLAY, Interim CFO
- Wai Conrad, CEO, Counterpart Health
- Torricelli Robert G, Director